Recruiting NA Acute Respiratory Failure

Compares treatment options for Acute Respiratory Failure

Official title Closed-loop syncHronization vErsuS convenTional Synchronization in sPontaneously Breathing Adult Nonivasive ventilationPatients

ClinicalTrials.gov ID: NCT06357780

What this study is testing

What it's testing
The study is a multicentric prospective randomised cross-over study. It evaluates the compatibility of patients with the device without altering the routine treatment applied.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Adult patients older than 18 years of age
  • Hospitalized at the ICU or emergency department with the intention of treatment with Noninvasive ventilation at least for the upcoming 2 hours with...
  • Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the...

You likely can't join if

  • Formalized ethical decision to withhold or withdraw life support
  • Patient included in another treatment research study under consent
  • Patient already enrolled in the present study in a previous episode of respiratory failure
  • Pregnant woman
  • Patients deemed at high risk for the need of transportation from an intensive care unit or emergency department to another ward, diagnostic unit or...
  • Hemodynamic instability defined as a need of continuous infusion of epinephrine or norepinephrine \> 1 mg/h
See the full eligibility criteria
Who can join
  • Adult patients older than 18 years of age
  • Hospitalized at the ICU or emergency department with the intention of treatment with Noninvasive ventilation at least for the upcoming 2 hours with spontaneous breathing activity
  • Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the study by the investigator and prior to study participation
What rules you out
  • Formalized ethical decision to withhold or withdraw life support
  • Patient included in another treatment research study under consent
  • Patient already enrolled in the present study in a previous episode of respiratory failure
  • Pregnant woman
  • Patients deemed at high risk for the need of transportation from an intensive care unit or emergency department to another ward, diagnostic unit or any other hospital
  • Hemodynamic instability defined as a need of continuous infusion of epinephrine or norepinephrine \> 1 mg/h
  • Not being able to obtain reference waveforms due to technical or medical problems
  • Vulnerable population
  • Increase or decrease of ventilatory support either in pressures, fraction of inspired oxygen or mode of ventilation during study period

The study team makes the final eligibility decision.

Where it's taking place

  • Izmir, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Izmir, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.